Tildrakizumab Real-World Experience (T-REX) in Plaque Psoriasis: Meta-Analysis of Four Non-interventional Studies

20260 citationsJournal Articlegold Open Access

Authors

Athanasios Tsianakas · Zentralklinik Bad Berka

Nina Magnolo · Klinik und Poliklinik für Hautkrankheiten

Afra Kempf · Almirall (Germany)

Frank Andersohn · DB Engineering & Consulting (Germany)

Astrid Kirsch · Almirall (Germany)

Georgios Kokolakis · Humboldt-Universität zu Berlin

Dennis Niebel

Abstract

Tildrakizumab showed consistent effectiveness across different study populations. Substantial effectiveness was achieved over 28 weeks. Safety results were comparable across populations, without outliers in older patients or patients with higher disease burden. Graphical abstract available for this article.

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Spondyloarthritis Studies and Treatments Dermatology and Skin Diseases

Publication Details

Published in: Dermatology and Therapy

DOI: 10.1007/s13555-026-01713-1

Field-Weighted Citation Impact: 0.00

Command Palette

Tildrakizumab Real-World Experience (T-REX) in Plaque Psoriasis: Meta-Analysis of Four Non-interventional Studies

Authors

Abstract

Topics & Keywords

Publication Details